Brightsurf Science News & Current Events

May 30, 2009
Indiana U. research at the American College of Sports Medicine conference
Dozens of researchers at Indiana University participated in the American College of Sports Medicine conference.

Vandetanib shows clinical benefit when combined with docetaxel for lung cancer
When combined with standard chemotherapy, an international Phase III trial has shown that the oral targeted therapy vandetanib improves progression-free survival for patients with advanced non-small cell lung cancer, according to research from the University of Texas M.

Obesity and diabetes double risk of HF -- patients with both conditions 'very difficult' to treat
The twin epidemics of obesity and type 2 diabetes will continue to fuel an explosion in heart failure, already the world's most prevalent chronic cardiovascular disease, according to John McMurray, professor of cardiology at the Western Infirmary, Glasgow, and president of the Heart Failure Association.

Hearing, voice problems worsen seniors' communication skills
Hearing and vocal problems go hand-in-hand among the elderly more frequently than previously thought, according to researchers at Duke University Medical Center.

Vaccine shows therapeutic promise against advanced melanoma
A vaccine for one of the most lethal cancers, advanced melanoma, has shown improved response rates and progression-free survival for patients when combined with the immunotherapy drug, Interleukin-2, according to researchers from the University of Texas M.

Individualized treatment for heart failure is rarely available outside hospital
Telemonitoring systems, by which the symptoms of heart failure can be remotely assessed, now provide a strategy for the improved personalized care of patients, according to Professor John Cleland from the University of Hull, UK.

Surgery not necessary for most late-stage colorectal cancers
A new study shows that a large majority of patients who present with advanced colorectal cancer that has spread to other organs don't require immediate surgery to remove the primary tumor in the colon.

New treatment combination proves safe for head and neck cancer patients
Patients undergoing treatment for advanced head and neck cancers may respond well to the addition of gefinitib to chemotherapy, according to a study sponsored by the Eastern Cooperative Oncology Group and chaired by Ethan Argiris, M.D., associate professor of medicine, University of Pittsburgh School of Medicine.

Results from 8 late-breaking clinical trials presented at Heart Failure 2009
Results and updates from eight studies were presented during a late-breaking trials session at Heart Failure 2009.

Study shows drug combination improves outcome for advanced non-small cell lung cancer
A new, international study found that the combination of two drugs delays disease progression for patients with advanced non-small cell lung cancer.

NYP/Weill Cornell physician-scientists present at 2009 American Transplant Congress in Boston
NewYork-Presbyterian Hospital/Weill Cornell Medical Center physician-scientists are presenting exciting new research at the 2009 American Transplant Congress in Boston from May 30 to June 3.

Novel biomarkers in heart failure
Several new biomarkers have been recently described in heart failure syndrome either in stable chronic patients as in the settings of acute decompensation.

Recognizing signs and symptoms of acute HF
Although heart failure is a chronic condition, acute exacerbations are frequent and occur with serious complications; patients with heart failure and their families can help improve prognosis in acute events if they are taught to recognize the tell-tale signs of worsening condition and seek immediate medical help.

Ballerinas and female athletes share quadruple health threats
A study led by sports medicine researcher Anne Hoch, D.O., at the Medical College of Wisconsin in Milwaukee has revealed that young female professional dancers face the same health risks as young female athletes when they don't eat enough to offset the energy they spend, and stop menstruating as a consequence.

Pitt melanoma researchers present novel findings at ASCO
Eight newly identified genes help predict a melanoma patient's response to treatment, a new study from the University of Pittsburgh Cancer Institute suggests.

Better treatment selection and improved therapies -- key to improving prognosis in acute HF
Today, acute heart failure represents the most common reason for hospitalization in the over-65 population.

HF patients in France still encouraged to enjoy their food -- even if it's not as salty as before
The individualized management program of France's is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to